January 23rd, 2004 - Volume 18 - Issue 2 - Contributor Index

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

Violin, Michela; Cozzi-Lepri, Alessandro; Velleca, Rossella; More

AIDS. 18(2):227-235, January 23rd, 2004.

Virological phenotype switches under salvage therapy with lopinavir–ritonavir in heavily pretreated HIV-1 vertically infected children

Galán, Isabel; Jiménez, José L; González-Rivera, Milagros; More

AIDS. 18(2):247-255, January 23rd, 2004.

Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097)

Katlama, Christine; Dominguez, Stéphanie; Gourlain, Karine; More

AIDS. 18(2):217-226, January 23rd, 2004.

Author:
Delwart, Eric L
Author:
Detels, Roger

Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097)

Katlama, Christine; Dominguez, Stéphanie; Gourlain, Karine; More

AIDS. 18(2):217-226, January 23rd, 2004.

A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis

Wallis, Robert S; Kyambadde, Peter; Johnson, John L; More

AIDS. 18(2):257-264, January 23rd, 2004.

Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097)

Katlama, Christine; Dominguez, Stéphanie; Gourlain, Karine; More

AIDS. 18(2):217-226, January 23rd, 2004.